Stavanger University Hospital HF
- Address
- Helse Stavanger HF, Postboks 8100, 4068 Stavanger, Norway
Stavanger University Hospital HF
Stavanger University Hospital HF is a comprehensive medical research institution conducting innovative clinical trials across multiple therapeutic areas. The center demonstrates particular strength in neuro-oncology, infectious disease management, endocrinology, and precision oncology, reflecting a commitment to advancing treatment strategies for both common and rare medical conditions.
- Glioblastoma and brain cancer therapy, investigating novel antiviral approaches combined with standard treatment protocols
- Infectious disease stewardship, focusing on antibiotic optimization in viral respiratory tract infections
- Endocrine disorders management, particularly primary adrenal insufficiency and hormone replacement optimization
- Precision oncology for rare and hard-to-treat cancers, utilizing targeted therapy repurposing strategies
The hospital's research portfolio emphasizes pragmatic trial design and patient-centered outcomes, including quality of life assessments and safety evaluations. Their work in antibiotic stewardship addresses critical antimicrobial resistance concerns, while their precision medicine initiatives in rare cancers represent cutting-edge approaches to matching patients with effective targeted therapies previously unavailable for their specific tumor types.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 14 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Helse Bergen HF2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Helse Bergen HF2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 112 other sites in Norway
Therapeutic Area Benchmark — Norway
Select a therapeutic area to compare against other sites in Norway.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Norway
Market Share
Country: Norway
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Stavanger University Hospital HF
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy and Safety of Sirolimus Versus Methylprednisolone in Patients with Active Thyroid Eye Disease | Helse Bergen HF | Phase III | Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cortisone | 1 | Unknown | 2023-08-03 | 2023-08-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.